China Resources Pharmaceutical Group Ltd. (640) Financial Statements

0 Followers

China Resources Pharmaceutical Group Ltd. Financial Overview

China Resources Pharmaceutical Group Ltd.'s market cap is currently €3.20B. The company's EPS TTM is €; its P/E ratio is 6.11; China Resources Pharmaceutical Group Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 300.01B	HK$ 274.18B	HK$ 270.40B	¥ 223.13B	¥ 193.24B
Gross Profit	HK$ 49.53B	HK$ 43.30B	HK$ 42.43B	¥ 34.36B	¥ 28.87B
Operating Income	HK$ 13.90B	HK$ 12.56B	HK$ 13.90B	¥ 9.49B	¥ 7.55B
EBITDA	HK$ 17.70B	HK$ 15.45B	HK$ 15.43B	¥ 13.59B	¥ 9.75B
Net Income	HK$ 4.50B	HK$ 3.57B	HK$ 4.24B	¥ 3.64B	¥ 3.08B
Balance Sheet
Cash & Short-Term Investments	HK$ 31.05B	HK$ 27.28B	HK$ 35.46B	¥ 28.56B	¥ 30.45B
Total Assets	HK$ 318.34B	HK$ 274.28B	HK$ 271.48B	¥ 214.19B	¥ 202.83B
Total Debt	HK$ 104.87B	HK$ 73.43B	HK$ 62.16B	¥ 56.06B	¥ 55.45B
Net Debt	HK$ 87.24B	HK$ 55.95B	HK$ 35.04B	¥ 34.89B	¥ 34.79B
Total Liabilities	HK$ 187.52B	HK$ 169.90B	HK$ 169.20B	¥ 134.14B	¥ 125.57B
Stockholders' Equity	HK$ 57.26B	HK$ 51.34B	HK$ 50.60B	¥ 43.52B	¥ 41.60B
Cash Flow
Free Cash Flow	HK$ 18.83B	HK$ 14.55B	HK$ 12.42B	¥ 6.62B	¥ 6.79B
Operating Cash Flow	HK$ 22.78B	HK$ 17.55B	HK$ 15.55B	¥ 9.57B	¥ 9.16B
Investing Cash Flow	HK$ -11.20B	HK$ -9.45B	HK$ -2.07B	¥ -2.90B	¥ -7.21B
Financing Cash Flow	HK$ -12.19B	HK$ -17.91B	HK$ -4.07B	¥ -7.90B	¥ 4.34B

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History

Income Statement >

China Resources Pharmaceutical Group Ltd. Debt to Assets

Balance Sheet >

China Resources Pharmaceutical Group Ltd. Cash Flow

Cash Flow >

China Resources Pharmaceutical Group Ltd. Forecast EPS vs Actual EPS

Earnings >